| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-05 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.2 | 0.0009 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.005 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.007 |